Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Jason Gonsky"'
Autor:
Edwin Chiu, Bachar Samra, Eric Tam, Babak Baseri, Bo Lin, Carol Luhrs, Jason Gonsky, Ahmed Sawas, Evelyn Taiwo, Gurinder Sidhu
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 548-556 (2020)
PURPOSE Adult T-cell lymphoma/leukemia (ATL) is a rare and aggressive peripheral T-cell malignancy caused by human T-cell lymphotropic virus-1 infection, which occurs in areas of high prevalence, predominantly in Japan and the Caribbean basin. Most A
Externí odkaz:
https://doaj.org/article/3c389e05cb3f42b98ac5a9cf7ba9f77c
Autor:
Adrienne A. Phillips, Paul A. Fields, Olivier Hermine, Juan C. Ramos, Brady E. Beltran, Juliana Pereira, Farooq Wandroo, Tatyana Feldman, Graham P. Taylor, Ahmed Sawas, Jeffrey Humphrey, Michael Kurman, Junji Moriya, Karen Dwyer, Mollie Leoni, Kevin Conlon, Lucy Cook, Jason Gonsky, Steven M. Horwitz
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
Mogamulizumab, a humanized defucosylated anti-C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine receptor 4-positive adult T-cell leukemia/lymphoma (ATL). This phase II study evaluated efficacy
Externí odkaz:
https://doaj.org/article/21f726b4425c427eabbb19608c81214f
Autor:
David J. Araten, Rosario Notaro, Howard T Thaler, Nancy Kernan, Farid Boulad, Hugo Castro-Malaspina, Trudy Small, Andromachi Scaradavou, Heather Magnan, Susan Prockop, Sara Chaffee, Jason Gonsky, Raymond Thertulien, Roberto Tarquini, Lucio Luzzatto
Publikováno v:
Haematologica, Vol 97, Iss 3 (2012)
Background Thrombosis is the major risk factor for death in patients with paroxysmal nocturnal hemoglobinuria. Previous case reports indicate that venous thrombosis in patients with paroxysmal nocturnal hemoglobinuria is amenable to thrombolysis.Desi
Externí odkaz:
https://doaj.org/article/05d17f96810b45449bbab82de8efa757
Autor:
Sassine, Ghanem, Jason, Gonsky
Publikováno v:
Cleveland Clinic Journal of Medicine. 89:91-98
Publikováno v:
European Urology. 79:330-333
Autor:
Kerin B. Adelson, Nina A. Bickell, Rebeca Franco, Sofya Pintova, Natalia Egorova, Cardinale B. Smith, Ryan Leibrandt, Jason Gonsky
Publikováno v:
JCO Oncology Practice. 16:e1499-e1506
PURPOSE: To describe the length of encounter during visits where goals-of-care (GoC) discussions were expected to take place. METHODS: Oncologists from community, academic, municipal, and rural hospitals were randomly assigned to receive a coaching m
Autor:
Eric Tam, Babak Baseri, Ahmed Sawas, Bachar Samra, Gurinder Sidhu, Bo Lin, Carol Luhrs, Jason Gonsky, Edwin Chiu, Evelyn Taiwo
Publikováno v:
JCO Global Oncology
PURPOSE Adult T-cell lymphoma/leukemia (ATL) is a rare and aggressive peripheral T-cell malignancy caused by human T-cell lymphotropic virus-1 infection, which occurs in areas of high prevalence, predominantly in Japan and the Caribbean basin. Most A
Autor:
Rebeca Franco, Ryan Leibrandt, Cardinale B. Smith, Nina A. Bickell, Jason Gonsky, Natalia N. Egorova, Kerin B. Adelson, Sofya Pintova
Publikováno v:
JCO Oncology Practice. 16:e290-e297
PURPOSE: To study factors that have an impact on the conduct of high-quality goals of care (GoC) discussions and productivity of oncologists among four different practice settings in patients with advanced cancer. METHODS: Solid-tumor oncologists fro
Publikováno v:
Eur Urol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2ce7f76470b7a770bd0890a8d78de76
https://europepmc.org/articles/PMC9793880/
https://europepmc.org/articles/PMC9793880/
Autor:
Olivier Hermine, Tatyana Feldman, Jason Gonsky, Juliana Pereira, Ahmed Sawas, Steven M. Horwitz, Brady E Beltran, Jeffrey Humphrey, Juan Carlos Ramos, Michael R. Kurman, Farooq Wandroo, Junji Moriya, Mollie Leoni, Karen Dwyer, Kevin C. Conlon, Adrienne A. Phillips, Graham P. Taylor, Paul Fields, Lucy Cook
Publikováno v:
Haematologica. 104:993-1003
Mogamulizumab, a humanized defucosylated anti C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine receptor 4-positive adult T-cell leukemia/lymphoma. This phase 2 study evaluated efficacy and sa